Melatonin and (−)-Epigallocatechin-3-Gallate: Partners in Fighting Cancer

Melatonin and (−)-Epigallocatechin-3-Gallate: Partners in Fighting Cancer

We have demonstrated previously that melatonin attenuates hepatotoxicity triggered by high doses of (−)-epigallocatechin-3-gallate (EGCG) in mice. The current work investigated the influence of melatonin on the oncostatic activity of EGCG in two cancer cell lines, wherein melatonin induced...

Full description

Bibliographic Details
Main Authors: Lingyun Zhang, Yufeng He, Ximing Wu, Guangshan Zhao, Ke Zhang, Chung S. Yang, Russel J. Reiter, Jinsong Zhang
Format: Article
Language:English
Published: MDPI AG 2019-07-01
Series:Cells
Subjects:
EGCG
melatonin
cancer
p21
quinoprotein
thioredoxin system
Online Access:https://www.mdpi.com/2073-4409/8/7/745

Internet

https://www.mdpi.com/2073-4409/8/7/745

Similar Items